Surprisingly however, IL-22BP levels were recently shown to be elevated in patients with IBD and thus limit the tissue-healing effects of IL-22, suggesting that a disturbed IL-22–IL-22BP axis might be one of the mechanisms contributing to the chronification of inflammation (Figure 1) (71, 72). This evidence concerns the gene IL22 and inflammatory bowel disease.